Follow
Lauren Cole Peres
Lauren Cole Peres
Assistant Member, H. Lee Moffitt Cancer Center and Research Institute
Verified email at moffitt.org
Title
Cited by
Cited by
Year
Invasive epithelial ovarian cancer survival by histotype and disease stage
LC Peres, KL Cushing-Haugen, M Köbel, HR Harris, A Berchuck, ...
JNCI: Journal of the National Cancer Institute 111 (1), 60-68, 2019
4612019
Idecabtagene vicleucel for relapsed/refractory multiple myeloma: real-world experience from the myeloma CAR T consortium
DK Hansen, S Sidana, LC Peres, C Colin Leitzinger, L Shune, ...
Journal of Clinical Oncology 41 (11), 2087-2097, 2023
1322023
Challenges and opportunities in studying the epidemiology of ovarian cancer subtypes
JA Doherty, LC Peres, C Wang, GP Way, CS Greene, JM Schildkraut
Current epidemiology reports 4, 211-220, 2017
872017
The Deepwater Horizon Oil Spill and Physical Health among Adult Women in Southern Louisiana: The Women and Their Children’s Health (WaTCH) Study
LC Peres, E Trapido, AL Rung, DJ Harrington, E Oral, Z Fang, E Fontham, ...
Environmental health perspectives 124 (8), 1208-1213, 2016
822016
Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the US, 1995–2005
L Cole, L Polfus, ES Peters
PloS one 7 (3), e32657, 2012
782012
Histotype classification of ovarian carcinoma: a comparison of approaches
LC Peres, KL Cushing-Haugen, M Anglesio, K Wicklund, R Bentley, ...
Gynecologic oncology 151 (1), 53-60, 2018
732018
High levels of C-reactive protein are associated with an increased risk of ovarian cancer: results from the Ovarian Cancer Cohort Consortium
LC Peres, AR Mallen, MK Townsend, EM Poole, B Trabert, NE Allen, ...
Cancer research 79 (20), 5442-5451, 2019
532019
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies
LC Peres, H Risch, KL Terry, PM Webb, MT Goodman, AH Wu, AJ Alberg, ...
International journal of epidemiology 47 (2), 460-472, 2018
512018
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma
JM Logue, LC Peres, H Hashmi, CM Colin-Leitzinger, AM Shrewsbury, ...
Blood Advances 6 (24), 6109-6119, 2022
502022
Association between body powder use and ovarian cancer: the African American Cancer Epidemiology Study (AACES)
JM Schildkraut, SE Abbott, AJ Alberg, EV Bandera, JS Barnholtz-Sloan, ...
Cancer Epidemiology, Biomarkers & Prevention 25 (10), 1411-1417, 2016
492016
Dietary inflammatory index and risk of epithelial ovarian cancer in African American women
LC Peres, EV Bandera, B Qin, KA Guertin, N Shivappa, JR Hebert, ...
International journal of cancer 140 (3), 535-543, 2017
452017
Targetable immune regulatory molecule expression in high-grade serous ovarian carcinomas in African American Women: a study of PD-L1 and IDO in 112 cases from the African …
AM Mills, LC Peres, A Meiss, KL Ring, SC Modesitt, SE Abbott, AJ Alberg, ...
International Journal of Gynecological Pathology 38 (2), 157-170, 2019
412019
Predictors of survival trajectories among women with epithelial ovarian cancer
LC Peres, S Sinha, MK Townsend, BL Fridley, BY Karlan, SK Lutgendorf, ...
Gynecologic oncology 156 (2), 459-466, 2020
382020
Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy
CJ Ferreri, MAT Hildebrandt, H Hashmi, LO Shune, JP McGuirk, ...
Blood cancer journal 13 (1), 117, 2023
352023
Analgesic medication use and risk of epithelial ovarian cancer in African American women
LC Peres, F Camacho, SE Abbott, AJ Alberg, EV Bandera, ...
British journal of cancer 114 (7), 819-825, 2016
352016
Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009–2012
M Watson, A Soman, EW Flagg, E Unger, D Deapen, VW Chen, LC Peres, ...
Preventive medicine 103, 60-65, 2017
302017
Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study
MA Mullins, LC Peres, AJ Alberg, EV Bandera, JS Barnholtz‐Sloan, ...
Cancer 125 (24), 4442-4451, 2019
292019
Challenges and opportunities in the statistical analysis of multiplex immunofluorescence data
CM Wilson, OE Ospina, MK Townsend, J Nguyen, C Moran Segura, ...
Cancers 13 (12), 3031, 2021
282021
Racial/ethnic disparities in ovarian cancer research
LC Peres, JM Schildkraut
Advances in cancer research 146, 1-21, 2020
282020
Safety and efficacy of standard of care (SOC) ciltacabtagene autoleucel (Cilta-cel) for relapsed/refractory multiple myeloma (RRMM).
DK Hansen, KK Patel, LC Peres, MH Kocoglu, L Shune, G Simmons, ...
Journal of Clinical Oncology 41 (16_suppl), 8012-8012, 2023
262023
The system can't perform the operation now. Try again later.
Articles 1–20